---
title: "Case Study: Development of a human iPSC-derived ALS model"
description: This case study describes how Ncardia successfully developed an iPSC-derived Amyotrophic Lateral Sclerosis model.
---

[Resources ](https://www.ncardia.com/insights/resources)

# [Case Study: Development of a human iPSC-derived ALS model](https://www.ncardia.com/insights/resources/case-study-development-of-a-human-ipsc-derived-als-model)

 Written by [Ncardia Stem Cell Experts](https://www.ncardia.com/insights/resources/author/ncardia) | February 6, 2023

Amyotrophic lateral sclerosis (ALS) is a rare neurological disease that primarily affects motor neurons responsible for controlling voluntary muscle movement. A hallmark of ALS is the accumulation of TDP-43 aggregates and the mis-splicing of STMN2, which can not be replicated with animal models. This hampers the development of disease-modifying therapies and creates a strong need to develop translational models that show disease-associated phenotypes and do replicate pathological mechanisms. 

In this case study, Ncardia generated a human iPSC-derived ALS model with TDP-43 mutant motor neurons* and developed specific assays to quantify disease-linked phenotypes such as mis-localization and aggregation of TDP-43, as well as STMN2 mis-splicing and electrophysiological dysfunction. Moreover, this unique in vitro cell model was generated without the need of a chemical stressor, which provides an even more physiologically relevant context to study ALS etiology and advance therapeutic development with high confidence. 

** iCell ® Motor Neurons, 01279 from FUJIFILM Cellular Dynamics, Inc.*

### This case study describes how Ncardia successfully generated an ALS disease model using motor neurons with a TDP-43 point mutation and developed assays to quantify disease relevant phenotypes.

#### ** Download the case study and discover the benefits:**

- A non-chemical induced *in vitro* model base on human biology
- Replication of the most relevant ALS associated phenotypes
- Custom assays and high-throughput screening readily available

[View full post](https://www.ncardia.com/insights/resources/case-study-development-of-a-human-ipsc-derived-als-model)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Ncardia Stem Cell Experts"
  },
  "dateModified" : "2026-05-11T12:59:59.792Z",
  "datePublished" : "2023-02-06T09:58:24Z",
  "headline" : "Case Study: Development of a human iPSC-derived ALS model",
  "image" : {
    "@type" : "ImageObject",
    "height" : 220,
    "url" : "https://www.ncardia.com/hubfs/Case%20Study%20Development%20of%20a%20human%20iPSC-derived%20ALS%20model.png",
    "width" : 350
  },
  "mainEntityOfPage" : "https://www.ncardia.com/insights/resources/case-study-development-of-a-human-ipsc-derived-als-model",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "Resources"
  }
}
```